Restorbio, inc. (TORC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating expenses:
Research and development

4,841

26,111

22,118

16,553

8,852

4,349

6,765

11,845

8,106

6,792

3,333

3,420

3,294

General and administrative

2,539

3,325

3,043

2,616

2,839

2,011

2,267

2,268

2,094

731

612

637

63

Total operating expenses

7,380

29,436

25,161

19,169

11,691

6,360

9,032

14,113

10,200

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

3,945

4,057

3,357

Loss from operations

-7,380

-29,436

-25,161

-19,169

-11,691

-6,360

-9,032

-14,113

-10,200

-7,523

-3,945

-4,057

-3,357

Other income, net

349

-2,266

725

847

631

-1,495

625

522

341

-

635

-

0

Loss before income taxes

-7,031

-28,885

-24,436

-18,322

-11,060

-5,731

-8,407

-13,591

-9,859

-23,054

-3,310

-4,057

-3,357

Income tax expense

7

5

12

10

9

-

-

-

-

-

-

-

-

Net loss

-7,038

-28,890

-24,448

-18,332

-11,069

-5,757

-8,407

-13,591

-9,859

-23,054

-3,310

-4,057

-3,357

Net loss per share, basic and diluted

-0.19

-0.84

-0.68

-0.51

-0.38

-0.18

-0.30

-0.48

-0.46

-5.53

-0.75

-0.94

-1.20

Weighted-average common shares used in computing net loss per share, basic and diluted

36,445

36,309

36,217

35,684

29,014

28,140

28,046

28,046

21,523

4,537

4,408

4,302

2,789

Other comprehensive gain (loss):
Net loss

-7,038

-28,890

-24,448

-18,332

-11,069

-5,757

-8,407

-13,591

-9,859

-

-3,310

-4,057

-

Net unrealized (losses) gains on marketable securities

-17

-60

-61

138

73

-

-46

-30

-

-

-

-

-

Comprehensive loss

-7,055

-28,950

-24,509

-18,194

-10,996

-5,722

-8,453

-13,621

-9,859

-

-3,310

-4,057

-